HAIR-AN syndrome

HAIR-AN syndrome consists of hyperandrogenism (HA), insulin resistance (IR), and acanthosis nigricans (AN).[1]:507[2]

Although it is a rare subset of polycystic ovary syndrome,[3] studies on patients with HAIR-AN played a key role in elucidating the pathogenesis of the former. In particular, although HAIR-AN results from two very different types of abnormalities - blocking antibodies against the insulin receptor OR genetically absent/reduced insulin receptor number/function - patients with both types have high levels of androgens (male hormones).

Research on the two types of HAIR-AN demonstrated that patients with both forms of HAIR-AN had very high levels of insulin and, critically, that it was the high insulin that caused the elevation in androgens. In other words, regardless of how it comes about, high levels of insulin lead to high levels of androgens. This insight had important implications for the understanding of the more common form of polycystic ovarian syndrome and ultimately led to new treatments for it, such as metformin.

See also

References

  1. ↑ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
  2. ↑ Somani N, Harrison S, Bergfeld WF (2008). "The clinical evaluation of hirsutism". Dermatol Ther. 21 (5): 376–91. doi:10.1111/j.1529-8019.2008.00219.x. PMID 18844715.
  3. ↑ Rager KM, Omar HA (2006). "Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN". ScientificWorldJournal. 6: 116–21. doi:10.1100/tsw.2006.23. PMID 16435040.


This article is issued from Wikipedia - version of the 5/26/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.